Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Other financing activities (2016 - 2024)

Utah Medical Products has reported Other financing activities over the past 15 years, most recently at $1000.0 for Q4 2024.

  • Quarterly results put Other financing activities at $1000.0 for Q4 2024, changed N/A from a year ago — trailing twelve months through Sep 2025 was $1000.0 (down 95.0% YoY), and the annual figure for FY2024 was $21000.0, up 75.0%.
  • Other financing activities for Q4 2024 was $1000.0 at Utah Medical Products, down from $11000.0 in the prior quarter.
  • Over the last five years, Other financing activities for UTMD hit a ceiling of $28000.0 in Q4 2021 and a floor of $1000.0 in Q4 2024.
  • Median Other financing activities over the past 5 years was $5500.0 (2021), compared with a mean of $7083.3.
  • Biggest five-year swings in Other financing activities: plummeted 78.57% in 2022 and later skyrocketed 350.0% in 2024.
  • Utah Medical Products' Other financing activities stood at $4000.0 in 2020, then skyrocketed by 600.0% to $28000.0 in 2021, then plummeted by 78.57% to $6000.0 in 2022, then crashed by 50.0% to $3000.0 in 2023, then crashed by 66.67% to $1000.0 in 2024.
  • The last three reported values for Other financing activities were $1000.0 (Q4 2024), $11000.0 (Q2 2024), and $9000.0 (Q1 2024) per Business Quant data.